Aeginis

Product 04 of 14

A probiotic aimed at the gut-bone connection.

1Concept
2Research programme
3In development
4Ground-tested
5Analog or flight

In microgravity the skeleton is unloaded and astronauts lose roughly 1 to 2% of bone density a month. Exercise and nutrition help but do not fully solve it, and no simple oral countermeasure exists.

The Bone-Support Probiotic is a research programme based on the gut-bone connection. In early studies by other groups, a Lactobacillus strain reduced unloading-related bone loss in mice. We are studying whether a well-characterised strain in a stable format could support bone health in crews.

This is early-stage science. Mouse results do not translate directly to people, which is why the programme starts with evidence grading and a strain safety screen.

The problem

1-2%

Astronauts lose roughly 1 to 2% of bone density a month in microgravity.

Source: published spaceflight studies and NASA planning figures; refers to work by other groups.

The science

Why this approach.

Bone is constantly rebuilt in response to load. In microgravity the load is removed, bone resorption rises and astronauts lose roughly 1 to 2% of bone density a month. Exercise, nutrition and sometimes drugs are used to slow the loss, but the problem grows with mission length.

A body of work by other groups suggests that gut microbes influence bone turnover through immune signalling and nutrient handling. In early studies, a Lactobacillus strain reduced unloading-related bone loss in mice. Mouse studies are a starting point, not proof for people. This programme begins by grading that evidence, characterising candidate strains and defining the human-relevant endpoints that would be needed.

In use

Across the length of a mission.

How this product is intended to fit into a crew's routine, from loading to return.

Design

Four decisions that shape it.

Evidence first

Published studies graded by organism, duration and setting so mouse results are not mistaken for crew results.

Strain selection

Candidate strains screened for safety and for the traits linked to bone outcomes.

Stable format

Delivered in the spore or other shelf-stable format used across the programme.

Combination potential

Could pair with the On-Demand Peptide Library's bone-building peptide.

Risks

What could go wrong, and what we do about it.

RiskHow we address it
Mouse-to-human gapNo crew claim until human-relevant evidence exists; endpoints defined in advance.
Strain-specific effectsStrain-level characterisation rather than assuming genus-level results.
Confounding by exercise and dietStudy design that separates the probiotic from other countermeasures.

Test plan

Ground, analog, orbit.

A staged programme: ground first, then analog crews, then flight.

Step 1

Ground testing

Strain characterisation, storage stability and cell-model work.

Step 2

Isolated-crew studies

Biomarker studies in analog populations if earlier stages succeed.

Step 3

Flight testing

Considered only after strong ground data.

Step 4

Partnerships

Bone-physiology groups and space-medicine institutes.

Questions

FAQ.

Is there proof it works in people?

No. The published signal is early and from mice. This is a research programme.

Why a probiotic for bone?

Gut microbes influence inflammation and nutrient handling, both linked to bone turnover.

All products on this site are under research and development. They are not approved or cleared by any regulator and are not available for sale. Nothing here is medical advice, and no product is intended to diagnose, treat, cure or prevent any disease. Descriptions of research refer to published studies by other groups and do not claim that our products have been proven in space. Bone-Support Probiotic is a product under research and development and is not available for sale.

Let's build the next shield together.

Space agencies, station builders, research institutes and sustainable-construction partners: we would like to hear from you.